Prestige Wealth Management Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-149
Closed -$32K 1062
2021
Q1
$32K Sell
149
-15
-9% -$2.82K 0.01% 295
2020
Q4
$19K Hold
164
0.01% 366
2020
Q3
$16K Hold
164
﹤0.01% 382
2020
Q2
$20K Buy
164
+15
+10% +$1.7K 0.01% 340
2020
Q1
$13K Hold
149
0.01% 344
2019
Q4
$16K Sell
149
-15
-9% -$1.68K 0.01% 313
2019
Q3
$19K Hold
164
0.01% 289
2019
Q2
$28K Sell
164
-21
-11% -$3.63K 0.02% 233
2019
Q1
$31K Sell
185
-17
-8% -$2.53K 0.02% 224
2018
Q4
$20K Buy
+202
New +$26.5K 0.01% 312

Other funds holding GWPH

Prestige Wealth Management Group's GWPH Position: Q2 2021 in Review

Prestige Wealth Management Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 149 shares — an estimated $32K sold.

Prestige Wealth Management Group first reported a position in GWPH in Q4 2018 and held it in 10 quarters. The position peaked at $32K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Prestige Wealth Management Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Prestige Wealth Management Group sold 149 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $32K.
  • Prestige Wealth Management Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
  • Prestige Wealth Management Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $32K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Prestige Wealth Management Group's 13F filing for Q2 2021, filed 12 Aug 2021.